The invention relates to new substituted heteroaryls of formula 1wherein A is selected from the group consisting of N and CH D is selected from the group consisting of CH, E is selected from the group consisting of C end N, T is C, G is selected from the group consisting of C and N, and wherein each of the broken (dotted) double bonds in ring 1 are selected from either a single bond or a double bond under the proviso that all single and double bonds of ring 1 are arranged in such a way that they all form together with ring 2 an aromatic ring system, and wherein R1, M and R3 are defined according to claim 1, and to the above compounds for the treatment of a disease selected from the group consisting of asthma, COPD, allergic rhinitis, allergic dermatitis, lupus erythematodes, lupus nephritis and rheumatoid arthritis.本發明係關於新穎的經取代之式1雜芳基化合物,其中A係選自由N及CH組成之群,D係選自由CH組成之群,E係選自由C及N組成之群;T為C,G係選自由C及N組成之群;且其中環1中之虛線(點線)雙鍵各選自單鍵或雙鍵,其限制條件為環1中之所有單鍵及雙鍵的方式排列可以使得其皆與環2一起形成芳族環系,且其中R1、M及R3如技術方案1所定義;及上述化合物用於治療選自由以下組成之群的疾病:哮喘、COPD、過敏性鼻炎、過敏性皮炎、紅斑狼瘡、狼瘡腎炎及類風濕性關節炎。